261 related articles for article (PubMed ID: 10864307)
1. Alzheimer's disease. Closing in on gamma-secretase.
De Strooper B
Nature; 2000 Jun; 405(6787):627, 629. PubMed ID: 10864307
[No Abstract] [Full Text] [Related]
2. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.
Esler WP; Kimberly WT; Ostaszewski BL; Diehl TS; Moore CL; Tsai JY; Rahmati T; Xia W; Selkoe DJ; Wolfe MS
Nat Cell Biol; 2000 Jul; 2(7):428-34. PubMed ID: 10878808
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
4. [The complex enzymic process yielding beta-amyloid protein in Alzheimer's disease].
Sela B
Harefuah; 2000 Jul; 139(1-2):42-7. PubMed ID: 10979452
[No Abstract] [Full Text] [Related]
5. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells.
Herreman A; Serneels L; Annaert W; Collen D; Schoonjans L; De Strooper B
Nat Cell Biol; 2000 Jul; 2(7):461-2. PubMed ID: 10878813
[No Abstract] [Full Text] [Related]
6. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.
Li YM; Xu M; Lai MT; Huang Q; Castro JL; DiMuzio-Mower J; Harrison T; Lellis C; Nadin A; Neduvelil JG; Register RB; Sardana MK; Shearman MS; Smith AL; Shi XP; Yin KC; Shafer JA; Gardell SJ
Nature; 2000 Jun; 405(6787):689-94. PubMed ID: 10864326
[TBL] [Abstract][Full Text] [Related]
7. [Alzheimer's disease: focus on beta-amyloid and gamma-secretase].
Iwatsubo T
Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1086-90. PubMed ID: 15168534
[No Abstract] [Full Text] [Related]
8. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease.
Selkoe DJ
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11039-41. PubMed ID: 11572965
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
[TBL] [Abstract][Full Text] [Related]
10. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
11. FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.
Xia W; Ostaszewski BL; Kimberly WT; Rahmati T; Moore CL; Wolfe MS; Selkoe DJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):673-81. PubMed ID: 11114265
[TBL] [Abstract][Full Text] [Related]
12. Proprotein convertase activity contributes to the processing of the Alzheimer's beta-amyloid precursor protein in human cells: evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway.
Lopez-Perez E; Seidah NG; Checler F
J Neurochem; 1999 Nov; 73(5):2056-62. PubMed ID: 10537065
[TBL] [Abstract][Full Text] [Related]
13. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1.
Zhang Z; Nadeau P; Song W; Donoviel D; Yuan M; Bernstein A; Yankner BA
Nat Cell Biol; 2000 Jul; 2(7):463-5. PubMed ID: 10878814
[No Abstract] [Full Text] [Related]
14. [Beta-amyloid protein: recent progress in basic research and therapeutic approaches].
Iwatsubo T
Rinsho Shinkeigaku; 2001 Dec; 41(12):1198-200. PubMed ID: 12235837
[TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease. A technical KO of amyloid-beta peptide.
Haass C; Selkoe DJ
Nature; 1998 Jan; 391(6665):339-40. PubMed ID: 9450743
[No Abstract] [Full Text] [Related]
17. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease. A partner for presenilin.
Schenk D
Nature; 2000 Sep; 407(6800):34-5. PubMed ID: 10993060
[No Abstract] [Full Text] [Related]
19. Presenilin-directed inhibitors of gamma-secretase trigger caspase 3 activation in presenilin-expressing and presenilin-deficient cells.
Alves da Costa C; Ayral E; Hernandez JF; St George-Hyslop P; Checler F
J Neurochem; 2004 Aug; 90(4):800-6. PubMed ID: 15287885
[TBL] [Abstract][Full Text] [Related]
20. Assembly and activation of the gamma-secretase complex: roles of presenilin cofactors.
Iwatsubo T
Mol Psychiatry; 2004 Jan; 9(1):8-10. PubMed ID: 14581930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
